Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker

Circulating tumor DNA analysis in breast cancer: is it ready for prime-time?

(2019) Giuseppe Buono et al.   CANCER TREATMENT REVIEWS

Prognostic significance of serum lactate dehydrogenase in patients with breast cancer: a meta-analysis

(2019) Dongbo Liu et al.   Cancer Management and Research

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer

(2018) Zhenya Jia et al.   Oncotarget

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies

(2018) Maria Apicella et al.   Cell Metabolism

Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy

(2018) Yangbo Feng et al.   Cancer Medicine

Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis

(2017) Tieying Dong et al.   Scientific Reports

Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

(2016) Jie Shen et al.   PLoS One

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer

(2016) Bo Chen et al.   Journal of Cancer

Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies

(2015) Fausto Petrelli et al.   ACTA ONCOLOGICA

Lactate dehydrogenase 5: An old friend and a new hope in the war on cancer

(2015) Katarzyna Augoff et al.   CANCER LETTERS

Lactic dehydrogenase and cancer an overview

(2015) Silvio Naviglio   Frontiers in Bioscience-Landmark

Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes

(2015) Dong Soo Lee et al.   TUMOR BIOLOGY

Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer

(2015) Jie Chen et al.   FEBS Open Bio

Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma

(2015) Maria Gkotzamanidou et al.   Clinical Lymphoma Myeloma & Leukemia

Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer

(2014) Xiaoan Liu et al.   CARCINOGENESIS

The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer

(2014) Zhi Zhao et al.   DISEASE MARKERS

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

(2014) M. Bonotto et al.   ONCOLOGIST

Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy

(2013) Ping Miao et al.   IUBMB LIFE

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

(2012) M Scartozzi et al.   BRITISH JOURNAL OF CANCER

Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry

(2011) Seho Park et al.   BREAST

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis

(2010) Andreas Hermes et al.   RESPIRATORY MEDICINE

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Cell Metabolism: Warburg and Beyond

(2008) Peggy P. Hsu et al.   CELL